Table 2.
Frequency and prevalence of associated congenital anomaly among individuals with craniofacial anomalies and intellectual disability.
| Congenital anomalies diagnostic category (BPA-ICD9 code) | Craniofacial anomalies | Orofacial clefts | Craniosynostosis | Craniofacial microsomia | Other congenital anomalies | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| All ID (n = 134) | Severe ID (n = 17) | All ID (n = 89) | Severe ID (n = 11) | All ID (n = 34) | Severe ID (n ≤ 5) | All ID (n = 10) | Severe ID (n ≤ 5) | All ID (n = 2515) | Severe ID (n = 378) | |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Chromosomal abnormalities (75800- 75899) | 22 (16.4) | ≤5 | 18 (20.2) | ≤5 | ≤5 | 0 | 0 | 0 | 769 (30.6) | 104 (27.5) |
| Foetal alcohol syndrome (75992) | ≤5 | 0 | ≤5 | 0 | ≤5 | 0 | 0 | 0 | 47 (1.9) | 6 (1.6) |
| System affected | ||||||||||
| Nervous (74000–74299) | 32 (23.9)a | 9 (52.9)b | 19 (21.4) | 6 (54.6) | 10 (29.4) | ≤5 | ≤5 | ≤5 | 464 (18.5) | 134 (35.5) |
| Cardiovascular (74500–74788) | 22 (16.4) | ≤5 | 15 (16.9) | ≤5 | ≤5 | 0 | ≤5 | ≤5 | 591 (23.5) | 65 (17.2) |
| Respiratory (74800–74888) | 8 (6.0) | ≤5 | ≤5 | ≤5 | ≤5 | 0 | 0 | 0 | 25 (1.0) | ≤5 |
| Gastrointestinal (75000–75188) | 10 (7.5) | ≤5 | 8 (9.0) | ≤5 | ≤5 | 0 | 0 | 0 | 159 (6.3) | 27 (7.1) |
| Urogenital (75200–75399) | 24 (17.9) | ≤5 | 17 (19.1) | ≤5 | 6 (17.7) | 0 | 0 | 0 | 498 (19.8) | 49 (13.0) |
| Musculoskeletal (75400–75699)c | 65 (48.5) | 10 (58.8) | 37 (41.6) | ≤5 | 19 (55.9) | ≤5 | 8 (80.0) | ≤5 | 537 (21.4) | 82 (21.7) |
| Integument (75710–75792) | 8 (6.0) | ≤5 | ≤5 | 0 | ≤5 | ≤5 | ≤5 | 0 | 94 (3.7) | 10 (2.6) |
BPA British Paediatric Association, ICD International Classification of Diseases, ID intellectual disability.
aIncludes microcephaly (n = 12) and corpus callosum agenesis (n = 8).
bIncludes microcephaly (n ≤ 5), corpus callosum agenesis (n = ≤5) and holoprosencephaly (n = ≤5).
cDoes not include oral clefts, craniosynostosis and related syndromes, craniofacial microsomia and other contributing syndromes.